Cargando…
HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients
PURPOSE: This study aimed to evaluate the clinical value of high-intensity focused ultrasound (HIFU) combined with gemcitabine (GEM) in treating unresectable pancreatic ductal adenocarcinoma (PDAC). PATIENTS AND METHODS: A total of 523 unresectable PDAC patients were recruited from December 30, 2007...
Autores principales: | Ning, Zhouyu, Xie, Jing, Chen, Qiwen, Zhang, Chenyue, Xu, Litao, Song, Libin, Meng, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362964/ https://www.ncbi.nlm.nih.gov/pubmed/30774386 http://dx.doi.org/10.2147/OTT.S185424 |
Ejemplares similares
-
Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma
por: Zhang, Chenyue, et al.
Publicado: (2017) -
High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells
por: Ning, Zhouyu, et al.
Publicado: (2019) -
Prognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma
por: Zhang, Chenyue, et al.
Publicado: (2016) -
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma
por: Zhu, Zhenfeng, et al.
Publicado: (2018) -
Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway
por: Wang, Haiyong, et al.
Publicado: (2016)